CanSino Biologics Inc. (HKG: 6185)
Hong Kong
· Delayed Price · Currency is HKD 31.10
-0.40 (-1.27%)
Jan 2, 2025, 10:36 AM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 11.32 billion as of January 3, 2025. Its market cap has decreased by -10.34% in one year.
Market Cap
11.32B
Enterprise Value
10.01B
Revenue
829.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.10
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 11.32B, an increase of 49.47%. That is a compound annual growth rate of 7.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 152.35B |
| Hansoh Pharmaceutical Group Company | 98.87B |
| JD Health International | 84.92B |
| WuXi Biologics | 68.94B |
| Sinopharm Group | 64.91B |
| Innovent Biologics | 58.07B |
| Sino Biopharmaceutical | 55.71B |
| CSPC Pharmaceutical Group | 53.23B |